SMTL ID : 3e8r.1 (1 other biounit)

Crystal structure of catalytic domain of TACE with hydroxamate inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.90 Å

Oligo State

monomer

Ligands

1 x ZN: ZINC ION(Non-covalent)

ZN.1: 5 residues within 4Å: Chain A: H.191, H.195, H.201 Ligands: 615.2, INN.3 5 PLIP interactions: 3 interactions with chain A, 1 Ligand-Ligand interactions, 1 Ligand-Water interactions Metal complexes: A:H.191, A:H.195, A:H.201, INN.3, H2O.6

1 x 615: (1R,2S)-N~2~-hydroxy-1-{4-[(2-phenylquinolin-4-yl)methoxy]benzyl}cyclopropane-1,2-dicarboxamide(Non-covalent)

615.2: 21 residues within 4Å: Chain A: G.132, T.133, L.134, G.135, L.136, E.184, L.187, V.188, H.191, E.192, H.195, H.201, Y.219, V.220, Y.222, P.223, I.224, A.225, N.233 Ligands: ZN.1, INN.3 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:L.134, A:E.184, A:E.184, A:L.187, A:V.188, A:H.191, A:A.225, A:A.225 Hydrogen bonds: A:G.132, A:L.134, A:G.135 pi-Stacking: A:H.191

1 x INN: N-{(2R)-2-[2-(hydroxyamino)-2-oxoethyl]-4-methylpentanoyl}-3-methyl-L-valyl-N-(2-aminoethyl)-L-alaninamide(Non-covalent)

INN.3: 17 residues within 4Å: Chain A: M.131, G.132, T.133, L.134, G.135, N.175, Y.176, H.191, E.192, H.195, H.201, Y.222, P.223, I.224, A.225 Ligands: ZN.1, 615.2 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:G.132, A:L.134, A:P.223, A:A.225 Water bridges: A:A.225

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Mazzola, R.D. et al., Discovery of novel hydroxamates as highly potent tumor necrosis factor-alpha converting enzyme inhibitors. Part II: optimization of the S3' pocket. Bioorg.Med.Chem.Lett. (2008)

Release Date

2008-10-21

Peptides

ADAM 17: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

ADAM 17

Related Entries With Identical Sequence